Hepatitis C and mental illness

by Dr V. R. Badrakalimuthu and Dr D. Rumball


Last updated: October 2013


It is estimated that around 216,000 individuals in the UK are chronically infected with the hepatitis C virus (HCV) (Health Protection Agency, 2012).


The prevalence of HCV infection among intravenous drug users varies between 53% and 96%. The prevalence in the sub-group of a population on methadone maintenance programme is between 67% and 96% (Novick, 2008).


Psychiatrists need to be aware of the important and complex issues involved in the treatment of substance use disorders presenting with co-occurring severe mental illness and HCV infection.


The aim of this module is to explore the relationship between hepatitis C and mental health and to offer guidance on management. This is particularly applicable to substance misuse and liaison psychiatrists as they deal with the complex areas of hepatitis C, substance misuse and the effects on physical and mental health.


Start the module



If you like this module, you may also be interested in:


Dual diagnosis: the diagnosis and treatment of depression with co-existing substance misuse by Dr Roger Bloor and Professor Ilana Crome


Essentials of Physical Health in Psychiatry (book from RCPsych Publications)



BJPsych Advances: related articles for CPD Online



Related Advances articles


Download take-home notes to print and annotateDownload take-home notes to print and annotate


© 2018 Royal College of Psychiatrists